Digital health platforms were already set up to prescribe online, ship medications directly to patients, drive patient engagement, and operate outside of traditional insurance systems
Thats part of why this conversation has generated so much local interest: patients are looking for something that works alongside not as a replacement for the diet and activity changes that are already difficult to sustain in a fast-paced urban routine
For individuals seeking evidence-based, regulated treatment for obesity or type 2 diabetes in the UK, there are several MHRA-approved and NICE-recommended options currently available, both through the NHS and via regulated private healthcare providers
Tirzepatide Mechanism Tirzepatide uses a GIP peptide backbone modified to retain potent GLP-1 receptor activity, creating a balanced dual agonist
We often start patients on semaglutide for cost reasons it works well and some people tolerate it perfectly
As GLP 1 receptor activation increases step by step, the brain and digestive tract recalibrate together